What Are the Therapeutic Implications of Targeting SMO?
Given the pivotal role of SMO in the Hedgehog signaling pathway, it has become a significant target for cancer therapy. SMO inhibitors, such as vismodegib and sonidegib, have been developed and approved for the treatment of advanced BCC. These inhibitors bind to SMO and prevent its activation, thereby inhibiting the downstream signaling that leads to tumor growth.